1. Home
  2. OLMA vs CPS Comparison

OLMA vs CPS Comparison

Compare OLMA & CPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • CPS
  • Stock Information
  • Founded
  • OLMA 2006
  • CPS 1960
  • Country
  • OLMA United States
  • CPS United States
  • Employees
  • OLMA N/A
  • CPS N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • CPS Auto Parts:O.E.M.
  • Sector
  • OLMA Health Care
  • CPS Consumer Discretionary
  • Exchange
  • OLMA Nasdaq
  • CPS Nasdaq
  • Market Cap
  • OLMA 560.7M
  • CPS 462.2M
  • IPO Year
  • OLMA 2020
  • CPS N/A
  • Fundamental
  • Price
  • OLMA $10.48
  • CPS $33.97
  • Analyst Decision
  • OLMA Strong Buy
  • CPS Hold
  • Analyst Count
  • OLMA 5
  • CPS 1
  • Target Price
  • OLMA $24.00
  • CPS $12.00
  • AVG Volume (30 Days)
  • OLMA 1.2M
  • CPS 161.1K
  • Earning Date
  • OLMA 11-11-2025
  • CPS 10-30-2025
  • Dividend Yield
  • OLMA N/A
  • CPS N/A
  • EPS Growth
  • OLMA N/A
  • CPS N/A
  • EPS
  • OLMA N/A
  • CPS 1.65
  • Revenue
  • OLMA N/A
  • CPS $2,719,148,000.00
  • Revenue This Year
  • OLMA N/A
  • CPS $2.31
  • Revenue Next Year
  • OLMA N/A
  • CPS $3.69
  • P/E Ratio
  • OLMA N/A
  • CPS $20.77
  • Revenue Growth
  • OLMA N/A
  • CPS N/A
  • 52 Week Low
  • OLMA $2.86
  • CPS $10.38
  • 52 Week High
  • OLMA $13.51
  • CPS $40.67
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 70.04
  • CPS 40.42
  • Support Level
  • OLMA $8.01
  • CPS $35.74
  • Resistance Level
  • OLMA $11.54
  • CPS $37.36
  • Average True Range (ATR)
  • OLMA 0.79
  • CPS 1.48
  • MACD
  • OLMA 0.14
  • CPS -0.77
  • Stochastic Oscillator
  • OLMA 72.61
  • CPS 11.68

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About CPS Cooper-Standard Holdings Inc.

Cooper-Standard Holdings Inc is engaged in the manufacture of sealing and fluid handling systems (consisting of fuel and brake delivery systems and fluid transfer systems). Its products are designed for passenger vehicles and light trucks that are manufactured by automotive original equipment manufacturers (OEMs) and replacement markets. It has two reportable segments: Sealing Systems and Fluid Handling Systems. The group's geographic regions are North America, Europe, Asia Pacific, and South America.

Share on Social Networks: